Skip to main content

J&J, Imerys Appeal to Reverse the $117 M Talc Verdict

J&J, Imerys Appeal to Reverse the $117 M Talc Verdict

J&J, Imerys Appeal to Reverse the $117 M Talc Verdict

Introduction

Defendants Johnson & Johnson and Imerys, its talc supplier, have appealed the $117 million New Jersey verdict announced earlier this month and deny the presence of asbestos in their products or that their talc can cause any form of cancer.
 
Mid-April, the New Jersey state jury awarded $117 million to the plaintiff, which was bifurcated as $37 million in compensatory damages and $ 80 Million in punitive damages. The case was heard in the Superior Court of the State of New Jersey, County of Middlesex. The plaintiff was seeking compensation for his diagnosis of mesothelioma (a cancer of the lung) allegedly caused by the asbestos present in the company’s Talcum Powder used over a long period. The jury agreed that the defendants showed reckless indifference in selling their Talcum powder that contained the controversial asbestos ingredient.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Study Links Roundup Chemical to Long-Term Brain Damage

Categories: Roundup

A recent study suggests that exposure to the widely used herbicide Roundup, which contains the active ingredient glyphosate, may be…

Zimmer Biomet Gets FDA Approval for Cementless Partial Knee

Zimmer Biomet announced it has received supplemental FDA premarket approval (PMA) for the Oxford Cementless Partial…

Court Names Special Masters for Bard Mesh Claim Settlements

Categories: Hernia Mesh

The U.S. District Judge overseeing the federal litigation involving Bard hernia mesh lawsuits has appointed two…

Demand Letter or Medical Record Review?     
Free Trials + 10% Discount!